Elite Pharmaceuticals, Inc. Exploration Abandonment and Impairment Expense
Elite Pharmaceuticals, Inc. (ELTP) reported Exploration Abandonment and Impairment Expense of $0 for the 6-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ExplorationAbandonmentAndImpairmentExpense · last filed 2023-11-14
| Period end | Exploration Abandonment and Impairment Expense 6 month | Exploration Abandonment and Impairment Expense 12 month |
|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $292.81K 10-Q · filed 2023-11-14 |